http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 21 Oct 2026 10:01:10 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Power+Solutions+International+refreshes+its+corporate+logo/27214578.html <p>Power Solutions International, Inc. (Nasdaq: PSIX) announced the introduction of a refreshed corporate logo, which the company says marks a milestone in the rollout of its Power Boost 2030 strategy.</p><p>The Wood Dale, Illinois-based company, which designs, engineers, and manufactures power systems and enclosures, said the updated visual identity accompanies what it is calling "PSI 2.0," a phase intended to expand its focus on the data center power market while maintaining its existing industrial and oil and gas operations.</p><p>According to a press release, the company said the logo change reflects a broader strategic direction toward becoming a more technology-driven power solutions http://www.streetinsider.com/Corporate+News/Power+Solutions+International+refreshes+its+corporate+logo/27214578.html Wed, 21 Oct 2026 10:01:10 -0400 PSIX http://www.streetinsider.com/Press+Releases/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html <p><strong>A New Look. A New Era. A New Journey Forward.</strong></p><p>WOOD DALE, Ill., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (Nasdaq: PSIX) (“PSI”), a leader in the design, engineering, and manufacturing of advanced power solutions and state-of-the-art enclosures, today announced the introduction of its refreshed corporate logo, marking an important milestone in the rollout of its <strong>Power Boost 2030</strong> vision and strategy.</p> <p>The refreshed identity opens a new chapter—<strong>PSI 2.0</strong>—as the Company builds on its established industrial and oil and gas expertise and accelerates its strategic focus on the growing data center power market. The new logo http://www.streetinsider.com/Press+Releases/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html Wed, 21 Oct 2026 10:00:00 -0400 PSIX http://www.streetinsider.com/Globe+Newswire/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html <p><strong>A New Look. A New Era. A New Journey Forward.</strong></p><p>WOOD DALE, Ill., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (Nasdaq: PSIX) (“PSI”), a leader in the design, engineering, and manufacturing of advanced power solutions and state-of-the-art enclosures, today announced the introduction of its refreshed corporate logo, marking an important milestone in the rollout of its <strong>Power Boost 2030</strong> vision and strategy.</p> <p>The refreshed identity opens a new chapter—<strong>PSI 2.0</strong>—as the Company builds on its established industrial and oil and gas expertise and accelerates its strategic focus on the growing data center power market. The new logo http://www.streetinsider.com/Globe+Newswire/Power+Solutions+International+Unveils+Refreshed+Corporate+Logo%2C+Marking+a+New+Chapter+in+Its+Power+Boost+2030+Vision/27214513.html Wed, 21 Oct 2026 10:00:00 -0400 PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html <p align="justify">PHILADELPHIA, Oct. 19, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Hub+Group%2C+Inc.+%28NASDAQ%3A+HUBG%29%3B+and+Power+Solutions+International%2C+Inc.+%28NA/27200422.html Mon, 19 Oct 2026 07:00:00 -0400 AARD CCB HUBG PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Press+Releases/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html <p align="justify">PHILADELPHIA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- <br /></p> <p align="justify"><strong><u>Aardvark Therapeutics, Inc. (NASDAQ: AARD)</u></strong><strong>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.</p> <p align="justify"><strong>What is This Investigation About?</strong> The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and http://www.streetinsider.com/Globe+Newswire/Attention+Long-Term+Shareholders+of+Aardvark+Therapeutics%2C+Inc.+%28NASDAQ%3A+AARD%29%3B+Coastal+Financial+Corporation+%28NASDAQ%3A+CCB%29%3B+Erasca%2C+Inc.+%28NASDAQ%3A+ERAS%29%3B+and+Power+Solutions+International%2C+Inc.+%28NASDA/27190290.html Thu, 15 Oct 2026 08:30:40 -0400 AARD CCB ERAS PSIX http://www.streetinsider.com/Press+Releases/Power+Solutions+International+Sets+Date+for+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27174295.html <p>WOOD DALE, Ill., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (Nasdaq: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, plans to conduct a conference call to discuss its third quarter 2026 results and business outlook on Thursday, November 5, 2026, at 5:00 p.m. Eastern time.</p> <p>After the close of the market on November 5 and prior to the conference call, Power Solutions International ("PSI") will issue a copy of the earnings press release via Globe Newswire. The press release may also be viewed on PSI’s website at http://www.streetinsider.com/Press+Releases/Power+Solutions+International+Sets+Date+for+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27174295.html Mon, 12 Oct 2026 09:00:00 -0400 PSIX http://www.streetinsider.com/Globe+Newswire/Power+Solutions+International+Sets+Date+for+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27174295.html <p>WOOD DALE, Ill., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (Nasdaq: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, plans to conduct a conference call to discuss its third quarter 2026 results and business outlook on Thursday, November 5, 2026, at 5:00 p.m. Eastern time.</p> <p>After the close of the market on November 5 and prior to the conference call, Power Solutions International ("PSI") will issue a copy of the earnings press release via Globe Newswire. The press release may also be viewed on PSI’s website at http://www.streetinsider.com/Globe+Newswire/Power+Solutions+International+Sets+Date+for+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27174295.html Mon, 12 Oct 2026 09:00:00 -0400 PSIX http://www.streetinsider.com/Press+Releases/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html <p align="justify">PHILADELPHIA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI)</u>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of shareholders of GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO).</p> <p align="justify"><strong>What Is This Investigation About? </strong>The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased</strong> <strong>GPGI, Inc., </strong><strong>f/k/a CompoSecure, Inc.</strong><strong> (NYSE: GPGI; CMPO)</strong> <strong>shares prior to November 3, 2025</strong><strong>, </strong><strong>and still hold shares today, </strong><strong>you can seek corporate reforms, the return of funds back to http://www.streetinsider.com/Press+Releases/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html Fri, 02 Oct 2026 08:25:29 -0400 GPGI NEHC NUAI PRCT PSIX http://www.streetinsider.com/Globe+Newswire/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html <p align="justify">PHILADELPHIA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI)</u>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of shareholders of GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO).</p> <p align="justify"><strong>What Is This Investigation About? </strong>The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased</strong> <strong>GPGI, Inc., </strong><strong>f/k/a CompoSecure, Inc.</strong><strong> (NYSE: GPGI; CMPO)</strong> <strong>shares prior to November 3, 2025</strong><strong>, </strong><strong>and still hold shares today, </strong><strong>you can seek corporate reforms, the return of funds back to http://www.streetinsider.com/Globe+Newswire/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html Fri, 02 Oct 2026 08:25:29 -0400 GPGI NEHC NUAI PRCT PSIX http://www.streetinsider.com/Press+Releases/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html <p align="justify">PHILADELPHIA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI)</u>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of shareholders of GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO).</p> <p align="justify"><strong>What Is This Investigation About? </strong>The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased</strong> <strong>GPGI, Inc., </strong><strong>f/k/a CompoSecure, Inc.</strong><strong> (NYSE: GPGI; CMPO)</strong> <strong>shares prior to November 3, 2025</strong><strong>, </strong><strong>and still hold shares today, </strong><strong>you can seek corporate reforms, the return of funds back to http://www.streetinsider.com/Press+Releases/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html Fri, 02 Oct 2026 08:25:29 -0400 GPGI NEHC NUAI PRCT PSIX http://www.streetinsider.com/Globe+Newswire/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html <p align="justify">PHILADELPHIA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong><u>GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI)</u>:</strong></p> <p align="justify">Grabar Law Office is investigating claims on behalf of shareholders of GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO).</p> <p align="justify"><strong>What Is This Investigation About? </strong>The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased</strong> <strong>GPGI, Inc., </strong><strong>f/k/a CompoSecure, Inc.</strong><strong> (NYSE: GPGI; CMPO)</strong> <strong>shares prior to November 3, 2025</strong><strong>, </strong><strong>and still hold shares today, </strong><strong>you can seek corporate reforms, the return of funds back to http://www.streetinsider.com/Globe+Newswire/GPGI%2C+Inc.%2C+fka+CompoSecure%2C+Inc.+%28NYSE%3A+GPGI%29%3B+New+Era+Energy+%26+Digital%2C+Inc.+%28NASDAQ%3A+NUAI%29%3B+Power+Solutions+International%2C+Inc.+%28NASDAQ%3A+PSIX%29%3B+and+PROCEPT+BioRobotics+Corporation+%28NASDAQ%3A+PRCT%29%3A/27139121.html Fri, 02 Oct 2026 08:25:29 -0400 GPGI NEHC NUAI PRCT PSIX